| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,507 | 71,930 | 3,078 | 3,152 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 5,507 | 71,930 | 3,078 | 3,152 | | | Operating Expenses | | Research Development | 9,857 | 10,202 | 9,959 | 11,470 | | Selling General and Administrative | 3,878 | 4,127 | 4,020 | 2,841 | | Non Recurring | (21) | 56 | (58) | (19) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,207) | 57,545 | (10,843) | (11,140) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (1,476) | 258 | 377 | | Earnings Before Interest And Taxes | (8,411) | 56,069 | (10,585) | (10,763) | | Interest Expense | (210) | 110 | 100 | 93 | | Income Before Tax | (8,201) | 55,959 | (10,685) | (10,856) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,201) | 55,959 | (10,685) | (10,856) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,201) | 55,959 | (10,685) | (10,856) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,201) | $55,959 | ($10,685) | ($10,856) |
|
1.27% Nasdaq 0.00%
Income Statement
